News

Under the two-year agreement, Kingchem will act as an agent to find a US pharmaceutical company to co-develop Sinobiopharma’s Chinese patented new version of cisatracurim besylate, a non-depolarizing

According to PPD, the acquisition expands its compound partnering program into dermatology, initially in the indications of psoriasis, atopic dermatitis and acne. With the acquisition, PPD gains a

The company expects to earn gross proceeds of approximately $31 million, before deducting placement agent’s fees and estimated offering expenses. The investors have agreed to purchase the units

Taro’s carbamazepine extended-release tablets are bioequivalent to the reference listed drug Tegretol-XR tablets of Novartis Pharmaceuticals, a prescription pharmaceutical product used for treating seizures. The FDA has informed

Alexion Pharmaceuticals, a biopharmaceutical company, has submitted a new drug application for Soliris as a treatment for patients with paroxysmal nocturnal hemoglobinuria to Japan’s Pharmaceuticals and Medical Devices

Nitec Pharma, a Switzerland-based specialty pharma company, has granted an exclusive license to Mundipharma International for the distribution of Lodotra in Europe. Under the terms of the agreement,

Financial Highlights Gross margin was 71.4% in the quarter, compared with 72.1% in the prior year quarter. Cash flow from operations for the nine months ended February 28,

Brad Nutter, chairman of Haemonetics’ board of directors, said, “We appreciate Rich’s leadership and guidance during his four-year tenure with Haemonetics. His breadth of experience in healthcare has

According the news source, the drug maker plans to close the plant in phases over a period of three years. The closure of the plant is expected to